Budget Amount *help |
¥8,320,000 (Direct Cost: ¥6,400,000、Indirect Cost: ¥1,920,000)
Fiscal Year 2022: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2021: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2020: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2019: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2018: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Outline of Final Research Achievements |
Diagnosis of cancer is necessary for the decision of cancer treatment for each patient. This study aimed to construct the molecular test information, which is required for differential diagnosis but scattered in many books, for the effective diagnostic workflow. This system can easily investigate molecular test information of all cancers regardless of the clinical department. This system is expected to reduce information gaps due to differences in doctors' experience and specialties, and contribute to improving patient benefits by receiving appropriate treatment.
|